Cardiac proteomic responses to ischemia-reperfusion injury and ischemic preconditioning

Expert Review of Proteomics

Volumn 8, Issue 2, 2011, Pages 241-261

  Kyu Kim, Hyoung ^a   Thu, Vu Thi ^a   Heo, Hye Jin ^a   Kim, Nari ^a   Han, Jin ^a  

^a Inje University   (South Korea)

Author keywords

cardiac myocyte; exercise; ischemia reperfusion injury; ischemic preconditioning; mitochondria

Indexed keywords

ACTIN; CALCIUM ION; CHAPERONE; CYTOCHROME C; CYTOCHROME C OXIDASE; ENDOTHELIAL NITRIC OXIDE SYNTHASE; FATTY ACID; GLUCOSE; HEAT SHOCK PROTEIN; MITOCHONDRIAL CREATINE KINASE; MYOSIN LIGHT CHAIN; NITRIC OXIDE; PROTEIN KINASE C EPSILON; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE;

BIOINFORMATICS; CELL REGENERATION; CELL SURVIVAL; CITRIC ACID CYCLE; CONGESTIVE CARDIOMYOPATHY; CYTOSKELETON; CYTOSOL; ENERGY CONVERSION; ENERGY YIELD; EXERCISE; FATTY ACID METABOLISM; GLUCOSE METABOLISM; GLYCOLYSIS; HEART CONTRACTION; HEART MUSCLE CONTRACTILITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; ISCHEMIC PRECONDITIONING; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MITOCHONDRIAL RESPIRATION; NONHUMAN; OXIDATIVE PHOSPHORYLATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN METABOLISM; PROTEIN MODIFICATION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; PROTEOMICS; REPERFUSION INJURY; RESPIRATORY CHAIN; REVIEW;

ANIMALS; HEART; HUMANS; ISCHEMIC PRECONDITIONING; MODELS, BIOLOGICAL; MYOCARDIUM; PROTEOMICS; REPERFUSION INJURY;

EID: 79955070592     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.11.8     Document Type: Review

References (138)

1. Jennings RB, Murry CE, Steenbergen C Jr, Reimer KA. Development of cell injury in sustained acute ischemia. Circulation 82(3 Suppl.), II2-II12 (1990).
2. Murata M, Akao M, O'Rourke B, Marban E. Mitochondrial ATP-sensitive potassium channels attenuate matrix Ca2+ overload during simulated ischemia and reperfusion: possible mechanism of cardioprotection. Circ. Res. 89(10), 891-898 (2001). (Pubitemid 34627894)
3. Turer AT, Hill JA. Pathogenesis of myocardial ischemia-reperfusion injury and rationale for therapy. Am. J. Cardiol. 106(3), 360-368 (2010).
4. Tompkins AJ, Burwell LS, Digerness SB, Zaragoza C, Holman WL, Brookes PS. Mitochondrial dysfunction in cardiac ischemia-reperfusion injury: ROS from complex I, without inhibition. Biochim. Biophys. Acta 1762(2), 223-231 (2006). (Pubitemid 43006028)
5. Thu V, Kim H, Ha S et al. Glutathione peroxidase 1 protects mitochondria against hypoxia/reoxygenation damage in mouse hearts. Pflügers Archiv. Eur. J. Physiol. 460(1), 55-68 (2010).
6. Chen Q, Moghaddas S, Hoppel CL, Lesnefsky EJ. Ischemic defects in the electron transport chain increase the production of reactive oxygen species from isolated rat heart mitochondria. Am. J. Physiol. Cell Physiol. 294(2), C460-C466 (2008). (Pubitemid 351276913)
7. Jennings RB, Reimer KA. The cell biology of acute myocardial ischemia. Ann. Rev. Med. 42(1), 225-246 (1991).
8. Reimer KA, Jennings RB, Tatum AH. Pathobiology of acute myocardial ischemia: metabolic, functional and ultrastructural studies. Am. J. Cardiol. 52(2), 72-81 (1983).
9. Murphy E, Steenbergen C. Mechanisms underlying acute protection from cardiac ischemia-reperfusion injury. Physiol. Rev. 88(2), 581-609 (2008). (Pubitemid 351520088)
10. Angelos MG, Kutala VK, Torres CA et al. Hypoxic reperfusion of the ischemic heart and oxygen radical generation. Am. J. Physiol. Heart Circ. Physiol. 290(1), H341-H347 (2006).
11. Cadenas S, Aragones J, Landazuri MO. Mitochondrial reprogramming through cardiac oxygen sensors in ischaemic heart disease. Cardiovasc. Res. 88(2), 219-228 (2010).
12. Suleiman MS, Halestrap AP, Griffiths EJ. Mitochondria: a target for myocardial protection. Pharmacol. Ther. 89(1), 29-46 (2001). (Pubitemid 32367882)
13. Kim J-S, Jin Y, Lemasters JJ. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion. Am. J. Physiol. Heart Circ. Physiol. 290(5), H2024-H2034 (2006).
14. Demaison L, Moreau D, Martine L, Chaudron I, Grynberg A. Myocardial ischemia and in vitro mitochondrial metabolic efficiency. Mol. Cell. Biochem. 158(2), 161-169 (1996). (Pubitemid 26187597)
15. Chen X, Zhang X, Kubo H et al. Ca2+ influx-induced sarcoplasmic reticulum Ca2+ overload causes mitochondrial-dependent apoptosis in ventricular myocytes. Circ. Res. 97(10), 1009-1017 (2005). (Pubitemid 41668914)
16. White MY, Tchen AS, McCarron HCK, Hambly BD, Jeremy RW, Cordwell SJ. Proteomics of ischemia and reperfusion injuries in rabbit myocardium with and without intervention by an oxygen-free radical scavenger. Proteomics 6(23), 6221-6233 (2006). (Pubitemid 44935510)
17. Kim N, Lee Y, Kim H et al. Potential biomarkers for ischemic heart damage identified in mitochondrial proteins by comparative proteomics. Proteomics 6(4), 1237-1249 (2006).
18. Hausenloy DJ, Duchen MR, Yellon DM. Inhibiting mitochondrial permeability transition pore opening at reperfusion protects against ischaemia-reperfusion injury. Cardiovasc. Res. 60(3), 617-625 (2003). (Pubitemid 37501119)
19. Shiki K, Hearse DJ. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am. J. Physiol. Heart Circ. Physiol. 253(6), H1470-H1476 (1987).
20. Makazan Z, Saini HK, Dhalla NS. Role of oxidative stress in alterations of mitochondrial function in ischemic-reperfused hearts. Am. J. Physiol. Heart Circ. Physiol. 292(4), H1986-H1994 (2007). (Pubitemid 46572425)
21. Maulik N, Yoshida T, Das DK. Regulation of cardiomyocyte apoptosis in ischemic reperfused mouse heart by glutathione peroxidase. Mol. Cell Biochem. 196(1), 13-21 (1999). (Pubitemid 29338774)
22. Murriel CL, Churchill E, Inagaki K, Szweda LI, Mochly-Rosen D. Protein kinase Cd activation induces apoptosis in response to cardiac ischemia and reperfusion damage: a mechanism involving BAD and the mitochondria. J. Biol. Chem. 279(46), 47985-47991 (2004). (Pubitemid 39540950)
23. Boudina S, Laclau MN, Tariosse L et al. Alteration of mitochondrial function in a model of chronic ischemia in vivo in rat heart. Am. J. Physiol. Heart Circ. Physiol. 282(3), H821-H831 (2002). (Pubitemid 34654916)
24. Solaini G, Harris DA. Biochemical dysfunction in heart mitochondria exposed to ischaemia and reperfusion. Biochem. J. 390(Pt 2), 377-394 (2005). (Pubitemid 41337100)
25. Hausenloy DJ, Yellon DM, Mani-Babu S, Duchen MR. Preconditioning protects by inhibiting the mitochondrial permeability transition. Am. J. Physiol. Heart Circ. Physiol. 287(2), H841-H849 (2004). (Pubitemid 38955321)
26. Kroemer G, Galluzzi L, Brenner C. Mitochondrial membrane permeabilization in cell death. Physiol. Rev. 87(1), 99-163 (2007). (Pubitemid 46209992)
27. Paradies G, Petrosillo G, Pistolese M, Di Venosa N, Federici A, Ruggiero FM. Decrease in mitochondrial complex I activity in ischemic/reperfused rat heart: involvement of reactive oxygen species and cardiolipin. Circ. Res. 94(1), 53-59 (2004). (Pubitemid 38064098)
28. Kobayashi K, Neely JR. Effects of ischemia and reperfusion on pyruvate dehydrogenase activity in isolated rat hearts. J. Mol. Cell Cardiol. 15(6), 359-367 (1983). (Pubitemid 13077442)
29. Korge P, Ping P, Weiss JN. Reactive oxygen species production in energized cardiac mitochondria during hypoxia/ reoxygenation: modulation by nitric oxide. Circ. Res. 103(8), 873-880 (2008).
30. Chen Q, Vazquez EJ, Moghaddas S, Hoppel CL, Lesnefsky EJ. Production of reactive oxygen species by mitochondria. J. Biol. Chem. 278(38), 36027-36031 (2003).
31. Lundberg KC, Szweda LI. Preconditioning prevents loss in mitochondrial function and release of cytochrome c during prolonged cardiac ischemia/reperfusion. Arch. Biochem. Biophys. 453(1), 130-134 (2006).
32. Crow MT, Mani K, Nam YJ, Kitsis RN. The mitochondrial death pathway and cardiac myocyte apoptosis. Circ. Res. 95(10), 957-970 (2004). (Pubitemid 39532326)
33. Valen G. Cellular signalling mechanisms in adaptation to ischemia-induced myocardial damage. Ann. Med. 35(5), 300-307 (2003). (Pubitemid 37013670)
34. Murry C, Jennings R, Reimer K. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation 74(5), 1124-1136 (1986). (Pubitemid 17174962)
35. Liu H, McPherson BC, Yao Z. Preconditioning attenuates apoptosis and necrosis: role of protein kinase Ce and -d isoforms. Am. J. Physiol. Heart Circ. Physiol. 281(1), H404-H410 (2001).
36. Zhu X, Liu B, Zhou S et al. Ischemic preconditioning prevents in vivo hyperoxygenation in postischemic myocardium with preservation of mitochondrial oxygen consumption. Am. J. Physiol. Heart Circ. Physiol. 293(3), H1442-H1450 (2007). (Pubitemid 47367187)
37. Cohen M, Liu G, Downey J. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation 84(1), 341-349 (1991).
38. Riess ML, Camara AKS, Chen Q, Novalija E, Rhodes SS, Stowe DF. Altered NADH and improved function by anesthetic and ischemic preconditioning in guinea pig intact hearts. Am. J. Physiol. Heart Circ. Physiol. 283(1), H53-H60 (2002). (Pubitemid 34705323)
39. Solenkova NV, Solodushko V, Cohen MV, Downey JM. Endogenous adenosine protects preconditioned heart during early minutes of reperfusion by activating Akt. Am. J. Physiol. Heart Circ. Physiol. 290(1), H441-H449 (2006).
40. Kuno A, Critz SD, Cui L et al. Protein kinase C protects preconditioned rabbit hearts by increasing sensitivity of adenosine A2b-dependent signaling during early reperfusion. J. Mol. Cell. Cardiol. 43(3), 262-271 (2007). (Pubitemid 47315714)
41. Inagaki K, Churchill E, Mochly-Rosen D. e protein kinase C as a potential therapeutic target for the ischemic heart. Cardiovasc. Res. 70(2), 222-230 (2006).
42. Imahashi K, Schneider MD, Steenbergen C, Murphy E. Transgenic expression of Bcl-2 modulates energy metabolism, prevents cytosolic acidification during ischemia, and reduces ischemia/reperfusion injury. Circ. Res. 95(7), 734-741 (2004). (Pubitemid 39331934)
43. Halestrap AP, Clarke SJ, Khaliulin I. The role of mitochondria in protection of the heart by preconditioning. Biochim. Biophys. Acta 1767(8), 1007-1031 (2007). (Pubitemid 47101788)
44. Ruiz-Meana M, Rodriguez-Sinovas A, Cabestrero A, Boengler K, Heusch G, Garcia-Dorado D. Mitochondrial connexin43 as a new player in the pathophysiology of myocardial ischaemia- reperfusion injury. Cardiovasc. Res. 77(2), 325-333 (2008). (Pubitemid 351197646)
45. O'Rourke B. Evidence for mitochondrial K+ channels and their role in cardioprotection. Circ. Res. 94(4), 420-432 (2004).
46. Garlid KD, Paucek P, Yarov-Yarovoy V et al. Cardioprotective effect of diazoxide and its interaction with mitochondrial ATP-sensitive K+ channels : possible mechanism of cardioprotection. Circ. Res. 81(6), 1072-1082 (1997). (Pubitemid 27514958)
47. O'Rourke B. Myocardial KATP channels in preconditioning. Circ. Res. 87(10), 845-855 (2000).
48. Onody A, Zvara A, Hackler L Jr, Vigh L, Ferdinandy P, Puskas LG. Effect of classic preconditioning on the gene expression pattern of rat hearts: a DNA microarray study. FEBS Lett. 536(1-3), 35-40 (2003). (Pubitemid 36206402)
49. Simkhovich BZ, Marjoram P, Poizat C, Kedes L, Kloner RA. Brief episode of ischemia activates protective genetic program in rat heart: a gene chip study. Cardiovasc. Res. 59(2), 450-459 (2003). (Pubitemid 37272039)
50. da Silva R, Lucchinetti E, Pasch T, Schaub MC, Zaugg M. Ischemic but not pharmacological preconditioning elicits a gene expression profile similar to unprotected myocardium. Physiol. Genomics 20(1), 117-130 (2004). (Pubitemid 40388511)
51. Sergeev P, da Silva R, Lucchinetti E et al. Trigger-dependent gene expression profiles in cardiac preconditioning: evidence for distinct genetic programs in ischemic and anesthetic preconditioning. Anesthesiology 100(3), 474-488 (2004). (Pubitemid 38268863)
52. Canatan H. The effect of cardiac ischemic preconditioning on rat left ventricular gene expression profile. Cell. Biochem. Funct. 26(2), 179-184 (2008). (Pubitemid 351373964)
53. Arrell DK, Neverova I, Fraser H, Marban E, Van Eyk JE. Proteomic analysis of pharmacologically preconditioned cardiomyocytes reveals novel phosphorylation of myosin light chain 1. Circ. Res. 89(6), 480-487 (2001). (Pubitemid 34132641)
54. Vondriska TM, Klein JB, Ping P. Use of functional proteomics to investigate PKC e-mediated cardioprotection: the signaling module hypothesis. Am. J. Physiol. Heart Circ. Physiol. 280(4), H1434-H1441 (2001).
55. Ping P, Zhang J, Pierce WM Jr, Bolli R. Functional proteomic analysis of protein kinase C e signaling complexes in the normal heart and during cardioprotection. Circ. Res. 88(1), 59-62 (2001). (Pubitemid 32064083)
56. Neverova I, Van Eyk JE. Application of reversed phase high performance liquid chromatography for subproteomic analysis of cardiac muscle. Proteomics 2(1), 22-31 (2002). (Pubitemid 34273095)
57. Schwertz H, Langin T, Platsch H et al. Two-dimensional analysis of myocardial protein expression following myocardial ischemia and reperfusion in rabbits. Proteomics 2(8), 988-995 (2002).
58. Sakai J, Ishikawa H, Kojima S, Satoh H, Yamamoto S, Kanaoka M. Proteomic analysis of rat heart in ischemia and ischemia-reperfusion using fluorescence two-dimensional difference gel electrophoresis. Proteomics 3(7), 1318-1324 (2003). (Pubitemid 36929554)
59. Mayr M, Metzler B, Chung YL et al. Ischemic preconditioning exaggerates cardiac damage in PKC-d null mice. Am. J. Physiol. Heart Circ. Physiol. 287(2), H946-H956 (2004). (Pubitemid 38955334)
60. Sawicki G, Jugdutt BI. Detection of regional changes in protein levels in the in vivo canine model of acute heart failure following ischemia-reperfusion injury: functional proteomics studies. Proteomics 4(7), 2195-2202 (2004). (Pubitemid 38880383)
61. De Celle T, Vanrobaeys F, Lijnen P et al. Alterations in mouse cardiac proteome after in vivo myocardial infarction: permanent ischaemia versus ischaemia-reperfusion. Exp. Physiol. 90(4), 593-606 (2005). (Pubitemid 40980160)
62. White MY, Cordwell SJ, McCarron HC et al. Proteomics of ischemia/reperfusion injury in rabbit myocardium reveals alterations to proteins of essential functional systems. Proteomics 5(5), 1395-1410 (2005).
63. Arrell DK, Elliott ST, Kane LA et al. Proteomic analysis of pharmacological preconditioning: novel protein targets converge to mitochondrial metabolism pathways. Circ. Res. 99(7), 706-714 (2006). (Pubitemid 44498304)
64. Buerke M, Schwertz H, Langin T et al. Proteome analysis of myocardial tissue following ischemia and reperfusion - effects of complement inhibition. Biochim. Biophys. Acta 1764(10), 1536-1545 (2006). (Pubitemid 44566478)
65. Bezstarosti K, Das S, Lamers JM, Das DK. Differential proteomic profiling to study the mechanism of cardiac pharmacological preconditioning by resveratrol. J. Cell. Mol. Med. 10(4), 896-907 (2006).
66. Fang JK, Prabu SK, Sepuri NB et al. Site specific phosphorylation of cytochrome c oxidase subunits I, IVi1 and Vb in rabbit hearts subjected to ischemia/ reperfusion. FEBS Lett. 581(7), 1302-1310 (2007). (Pubitemid 46452602)
67. Schwertz H, Carter JM, Abdudureheman M et al. Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor. Proteomics 7(24), 4579-4588 (2007).
68. Fert-Bober J, Basran RS, Sawicka J, Sawicki G. Effect of duration of ischemia on myocardial proteome in ischemia/ reperfusion injury. Proteomics 8(12), 2543-2555 (2008).
69. Chou HC, Chen YW, Lee TR et al. Proteomics study of oxidative stress and Src kinase inhibition in H9C2 cardiomyocytes: a cell model of heart ischemia-reperfusion injury and treatment. Free Radic. Biol. Med. 49(1), 96-108 (2010).
70. Warren CM, Geenen DL, Helseth DL Jr, Xu H, Solaro RJ. Sub-proteomic fractionation, iTRAQ, and OFFGEL-LC-MS/MS approaches to cardiac proteomics. J. Proteomics 73(8), 1551-1561 (2010).
71. Wong R, Aponte AM, Steenbergen C, Murphy E. Cardioprotection leads to novel changes in the mitochondrial proteome. Am. J. Physiol. Heart Circ. Physiol. 298(1), H75-H91 (2010).
72. Jensen LJ, Kuhn M, Stark M et al. STRING 8 - a global view on proteins and their functional interactions in 630 organisms. Nucleic Acids Res. 37(Database issue), D412-D416 (2008).
73. Mi H, Dong Q, Muruganujan A, Gaudet P, Lewis S, Thomas PD. PANTHER version 7: improved phylogenetic trees, orthologs and collaboration with the Gene Ontology Consortium. Nucl. Acids Res. 38(Suppl. 1), D204-D210 (2010).
74. Tatusov RL, Fedorova ND, Jackson JD et al. The COG database: an updated version includes eukaryotes. BMC Bioinformatics 4, 41 (2003).
75. Bindea G, Mlecnik B, Hackl H et al. ClueGO: a Cytoscape plug-in to decipher functionally grouped gene ontology and pathway annotation networks. Bioinformatics 25(8), 1091-1093 (2009).
76. Kanehisa M, Goto S, Hattori M et al. From genomics to chemical genomics: new developments in KEGG. Nucleic Acids Res. 34(Database issue), D354-D357 (2006).
77. Horton P, Park KJ, Obayashi T et al. WoLF PSORT: protein localization predictor. Nucleic Acids Res. 35(Web Server issue), W585-W587 (2007).
78. Chen Q, Camara AKS, Stowe DF, Hoppel CL, Lesnefsky EJ. Modulation of electron transport protects cardiac mitochondria and decreases myocardial injury during ischemia and reperfusion. Am. J. Physiol. Cell Physiol. 292(1), C137-C147 (2007). (Pubitemid 46115127)
79. Dyck JRB, Lopaschuk GD. AMPK alterations in cardiac physiology and pathology: enemy or ally? J. Physiol. 574(1), 95-112 (2006). (Pubitemid 43905800)
80. Brandt U. Energy converting NADH: quinone oxidoreductase (complex I). Annu. Rev. Biochem. 75(1), 69-92 (2006). (Pubitemid 44118026)
81. Crofts AR. The cytochrome bc1 complex: function in the context of structure. Annu. Rev. Physiol. 66, 689-733 (2004). (Pubitemid 40614460)
82. Petrosillo G, Ruggiero F, Di Venosa N, Paradies G. Decreased complex III activity in mitochondria isolated from rat heart subjected to ischemia and reperfusion: role of reactive oxygen species and cardiolipin. FASEB J. 17(6), 714-716 (2003).
83. Calhoun MW, Thomas JW, Gennis RB. The cytochrome oxidase superfamily of redox-driven proton pumps. Trends Biochem. Sci. 19(8), 325-330 (1994). (Pubitemid 24259984)
84. Yoshikawa S, Muramoto K, Shinzawa- Itoh K et al. Proton pumping mechanism of bovine heart cytochrome c oxidase. Biochim. Biophys. Acta 1757(9-10), 1110-1116 (2006). (Pubitemid 44442134)
85. Prabu SK, Anandatheerthavarada HK, Raza H, Srinivasan S, Spear JF, Avadhani NG. Protein kinase A-mediated phosphorylation modulates cytochrome c oxidase function and augments hypoxia and myocardial ischemia-related injury. J. Biol. Chem. 281(4), 2061-2070 (2006). (Pubitemid 43845794)
86. Yu Q, Nguyen T, Ogbi M, Caldwell RW, Johnson JA. Differential loss of cytochrome-c oxidase subunits in ischemia-reperfusion injury: exacerbation of COI subunit loss by PKC-e inhibition. Am. J. Physiol. Heart Circ. Physiol. 294(6), H2637-H2645 (2008).
87. Yotov WV, St-Arnaud R. Cloning and functional expression analysis of the a subunit of mouse ATP synthase. Biochem. Biophys. Res. Commun. 191(1), 142-148 (1993). (Pubitemid 23222614)
88. Hu D, Cao K, Peterson-Wakeman R, Wang R. Altered profile of gene expression in rat hearts induced by chronic nicotine consumption. Biochem. Biophys. Res. Commun. 297(4), 729-736 (2002). (Pubitemid 35230311)
89. Oliver MF, Opie LH. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343(8890), 155-158 (1994).
90. Lopaschuk GD, Belke DD, Gamble J, Itoi T, Schonekess BO. Regulation of fatty acid oxidation in the mammalian heart in health and disease. Biochim. Biophys. Acta 1213(3), 263-276 (1994). (Pubitemid 24262910)
91. McCormack JG, Barr RL, Wolff AA, Lopaschuk GD. Ranolazine stimulates glucose oxidation in normoxic, ischemic, and reperfused ischemic rat hearts. Circulation 93(1), 135-142 (1996). (Pubitemid 26007542)
92. Reed LJ. Regulation of mammalian pyruvate dehydrogenase complex by a phosphorylation-dephosphorylation cycle. Curr. Top. Cell Regul. 18, 95-106 (1981).
93. Patel MS, Korotchkina LG. Regulation of the pyruvate dehydrogenase complex. Biochem. Soc. Trans. 34(Pt 2), 217-222 (2006).
94. Patel TB, Olson MS. Regulation of pyruvate dehydrogenase complex in ischemic rat heart. Am. J. Physiol. 246(6 Pt 2), H858-H864 (1984). (Pubitemid 14077788)
95. Saiki Y, Lopaschuk GD, Dodge K, Yamaya K, Morgan C, Rebeyka IM. Pyruvate augments mechanical function via activation of the pyruvate dehydrogenase complex in reperfused ischemic immature rabbit hearts. J. Surg. Res. 79(2), 164-169 (1998). (Pubitemid 28467353)
96. Chen CH, Budas GR, Churchill EN, Disatnik MH, Hurley TD, Mochly-Rosen D. Activation of aldehyde dehydrogenase-2 reduces ischemic damage to the heart. Science 321(5895), 1493-1495 (2008).
97. Ma H, Guo R, Yu L, Zhang Y, Ren J. Aldehyde dehydrogenase 2 (ALDH2) rescues myocardial ischaemia/reperfusion injury: role of autophagy paradox and toxic aldehyde. Eur. Heart J. DOI: 10.1093/eurheartj/ehq253 (2010) (Epub ahead of print).
98. Kantor PF, Dyck JR, Lopaschuk GD. Fatty acid oxidation in the reperfused ischemic heart. Am. J. Med. Sci. 318(1), 3-14 (1999). (Pubitemid 30387269)
99. Barandon L, Dufourcq P, Costet P et al. Involvement of FrzA/sFRP-1 and the Wnt/frizzled pathway in ischemic preconditioning. Circ. Res. 96(12), 1299-1306 (2005). (Pubitemid 40962108)
100. Ding VW, Chen RH, McCormick F. Differential regulation of glycogen synthase kinase 3b by insulin and Wnt signaling. J. Biol. Chem. 275(42), 32475-32481 (2000).
101. Liu B, el Alaoui-Talibi Z, Clanachan AS, Schulz R, Lopaschuk GD. Uncoupling of contractile function from mitochondrial TCA cycle activity and MVO2 during reperfusion of ischemic hearts. Am. J. Physiol. 270(1 Pt 2), H72-H80 (1996).
102. Janero DR, Hreniuk D. Suppression of TCA cycle activity in the cardiac muscle cell by hydroperoxide-induced oxidant stress. Am. J. Physiol. Cell. Physiol. 270(6), C1735-C1742 (1996).
103. Tretter L, Adam-Vizi V. Inhibition of Krebs cycle enzymes by hydrogen peroxide: a key role of a-ketoglutarate dehydrogenase in limiting NADH production under oxidative stress. J. Neurosci. 20(24), 8972-8979 (2000). (Pubitemid 32042897)
104. Bittl JA, Weisfeldt ML, Jacobus WE. Creatine kinase of heart mitochondria. The progressive loss of enzyme activity during in vivo ischemia and its correlation to depressed myocardial function. J. Biol. Chem. 260(1), 208-214 (1985). (Pubitemid 15165305)
105. Rauch U, Schulze K, Witzenbichler B, Schultheiss HP. Alteration of the cytosolic-mitochondrial distribution of high-energy phosphates during global myocardial ischemia may contribute to early contractile failure. Circ. Res. 75(4), 760-769 (1994). (Pubitemid 24297647)
106. Rodriguez P, Avellanal M, Felizola A, Barrigon S. Importance of creatine kinase activity for functional recovery of myocardium after ischemia-reperfusion challenge. J. Cardiovasc. Pharmacol. 41(1), 97-104 (2003). (Pubitemid 36015061)
107. Welch WJ. Mammalian stress response: cell physiology, structure/function of stress proteins, and implications for medicine and disease. Physiol. Rev. 72(4), 1063-1081 (1992).
108. Soti C, Csermely P. Molecular chaperones and the aging process. Biogerontology 1(3), 225-233 (2000).
109. Latchman DS. Heat shock proteins and human disease. J. R. Coll. Phys. Lond. 25(4), 295-299 (1991).
110. Williams RS, Benjamin IJ. Protective responses in the ischemic myocardium. J. Clin. Invest. 106(7), 813-818 (2000).
111. Martin JL, Mestril R, Hilal-Dandan R, Brunton LL, Dillmann WH. Small heat shock proteins and protection against ischemic injury in cardiac myocytes. Circulation 96(12), 4343-4348 (1997). (Pubitemid 28007464)
112. Dillmann WH. Heat shock proteins and protection against ischemic injury. Infect. Dis. Obstet. Gynecol. 7(1-2), 55-57 (1999). (Pubitemid 29215671)
113. Asea A, Kraeft SK, Kurt-Jones EA et al. HSP70 stimulates cytokine production through a CD14-dependant pathway, demonstrating its dual role as a chaperone and cytokine. Nat. Med. 6(4), 435-442 (2000). (Pubitemid 30208161)
114. Xiao X, Benjamin IJ. Stress-response proteins in cardiovascular disease. Am. J. Hum. Genet. 64(3), 685-690 (1999). (Pubitemid 30460409)
115. Vander Heide RS. Increased expression of HSP27 protects canine myocytes from simulated ischemia-reperfusion injury. Am. J. Physiol. Heart Circ. Physiol. 282(3), H935-H941 (2002). (Pubitemid 34654930)
116. Morimoto RI. Regulation of the heat shock transcriptional response: cross talk between a family of heat shock factors, molecular chaperones, and negative regulators. Genes Dev. 12(24), 3788-3796 (1998). (Pubitemid 29024840)
117. Schaper J, Mulch J, Winkler B, Schaper W. Ultrastructural, functional, and biochemical criteria for estimation of reversibility of ischemic injury: a study on the effects of global ischemia on the isolated dog heart. J. Mol. Cell. Cardiol. 11(6), 521-541 (1979). (Pubitemid 9207431)
118. Jennings RB, Baum JH, Herdson PB. Fine structural changes in myocardial ischemic injury. Arch. Pathol. 79, 135-143 (1965).
119. Steenbergen C, Hill M, Jennings R. Cytoskeletal damage during myocardial ischemia: changes in vinculin immunofluorescence staining during total in vitro ischemia in canine heart. Circ. Res. 60(4), 478-486 (1987). (Pubitemid 17106716)
120. Hein S, Scheffold T, Schaper J. Ischemia induces early changes to cytoskeletal and contractile proteins in diseased human myocardium. J. Thoracic Cardiovasc. Surg. 110(1), 89-98 (1995).
121. Jaswal JS, Cadete VJJ, Lopaschuk GD. Optimizing cardiac energy substrate metabolism: a novel therapeutic intervention for ischemic heart disease. Heart Metab. 38, 5-14 (2008). (Pubitemid 351522688)
122. Ascensao A, Ferreira R, Magalhaes J. Exercise-induced cardioprotection - biochemical, morphological and functional evidence in whole tissue and isolated mitochondria. Int. J. Cardiol. 117(1), 16-30 (2007). (Pubitemid 46420357)
123. Demirel HA, Powers SK, Caillaud C et al. Exercise training reduces myocardial lipid peroxidation following short-term ischemia-reperfusion. Med. Sci. Sports Exerc. 30(8), 1211-1216 (1998). (Pubitemid 28369224)
124. Hamilton KL, Powers SK, Sugiura T et al. Short-term exercise training can improve myocardial tolerance to I/R without elevation in heat shock proteins. Am. J. Physiol. Heart Circ. Physiol. 281(3), H1346-H1352 (2001).
125. Iemitsu M, Maeda S, Jesmin S, Otsuki T, Miyauchi T. Exercise training improves aging-induced downregulation of VEGF angiogenic signaling cascade in hearts. Am. J. Physiol. Heart Circ. Physiol. 291(3), H1290-H1298 (2006). (Pubitemid 44343674)
126. Le Page C, Noirez P, Courty J, Riou B, Swynghedauw B, Besse S. Exercise training improves functional post-ischemic recovery in senescent heart. Exp. Gerontol. 44(3), 177-182 (2009).
127. Powers SK, Quindry JC, Kavazis AN. Exercise-induced cardioprotection against myocardial ischemia-reperfusion injury. Free Radic. Biol. Med. 44(2), 193-201 (2008).
128. Boluyt MO, Brevick JL, Rogers DS, Randall MJ, Scalia AF, Li ZB. Changes in the rat heart proteome induced by exercise training: increased abundance of heat shock protein hsp20. Proteomics 6(10), 3154-3169 (2006). (Pubitemid 43806411)
129. Burniston JG. Adaptation of the rat cardiac proteome in response to intensity-controlled endurance exercise. Proteomics 9(1), 106-115 (2009).
130. Kavazis AN, Alvarez S, Talbert E, Lee Y, Powers SK. Exercise training induces a cardioprotective phenotype and alterations in cardiac subsarcolemmal and intermyofibrillar mitochondrial proteins. Am. J. Physiol. Heart Circ. Physiol. 297(1), H144-H152 (2009).
131. Sun B, Wang JH, Lv YY, Zhu SS, Yang J, Ma JZ. Proteomic adaptation to chronic high intensity swimming training in the rat heart. Comp. Biochem. Physiol. Part D Genom. Proteom. 3(1), 108-117 (2008). (Pubitemid 351250862)
132. Pereira-Leal JB, Levy ED, Teichmann SA. The origins and evolution of functional modules: lessons from protein complexes. Philos. Trans. R. Soc. Lond. B. Biol. Sci. 361(1467), 507-517 (2006). (Pubitemid 44870107)
133. Ping P. Getting to the heart of proteomics. N. Engl. J. Med. 360(5), 532-534 (2009).
134. Vladutiu GD. Heterozygosity: an expanding role in proteomics. Mol. Genet. Metab. 74(1-2), 51-63 (2001). (Pubitemid 32955147)
135. Yang JS, Kim JT, Jeon J et al. Changes in hepatic gene expression upon oral administration of taurine-conjugated ursodeoxycholic acid in ob/ob mice. PLoS One 5(11), e13858 (2010).
136. Deshpande R, Sharma S, Verfaillie CM, Hu WS, Myers CL. A scalable approach for discovering conserved active subnetworks across species. PLoS Comput. Biol. 6(12), e1001028 (2010).
137. Garlid KD, Costa AD, Quinlan CL, Pierre SV, Dos Santos P. Cardioprotective signaling to mitochondria. J. Mol. Cell. Cardiol. 46(6), 858-866 (2009).
138. Quinlan CL, Costa AD, Costa CL, Pierre SV, Dos Santos P, Garlid KD. Conditioning the heart induces formation of signalosomes that interact with mitochondria to open mitoKATP channels. Am. J. Physiol. Heart Circ. Physiol. 295(3), H953-H961 (2008).